Atara Biotherapeutics to Participate in Cell Therapy Panel Discussion at the Cowen 42nd Annual Virtual Healthcare Conference

Author's Avatar
Mar 02, 2022

Atara+Biotherapeutics%2C+Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal Touchon, President and Chief Executive Officer, will participate in a panel discussion focused on cell therapy at the Cowen 42nd Annual Virtual Healthcare Conference on Wednesday, March 9, 2022, at 9:10 a.m. EST.